Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity

BACKGROUND: Dipeptidyl peptidase 4 (DPP-4, also known as CD26) binds with adenosine deaminase (ADA) to activate T lymphocytes. Here, we investigated whether ADA activity is specifically affected by treatment with DPP-4 inhibitor (DPP4I) compared with other anti-diabetic agents. METHODS: Fasting ADA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae-Geun, Kang, Dong Gu, Yu, Jung Re, Kim, Youngree, Kim, Jinsoek, Koh, Gwanpyo, Lee, Daeho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122899/
https://www.ncbi.nlm.nih.gov/pubmed/21738897
http://dx.doi.org/10.4093/dmj.2011.35.2.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122899/
https://www.ncbi.nlm.nih.gov/pubmed/21738897
http://dx.doi.org/10.4093/dmj.2011.35.2.149

Ejemplares similares